Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1066 of 6351
-
Immunotherapy combo may keep rare head and neck cancer at bay
Disease control OngoingThe main objective will be to estimate the disease free survival (DFS) of patients with resectable head and neck mucosal melanomas treated by neo-adjuvant anti-PD1 (in combination or not with lenvatinib) followed by surgery, radiotherapy and maintenance immunotherapy in order to …
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New push to bring hepatitis c treatment to drug clinics
Disease control Recruiting nowThe overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and to develop a translational framework for subsequent establishment of HCV screening and trea…
Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for progressive MS: ocrelizumab trial targets disability
Disease control OngoingThis study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Immunotherapy may replace chemo for some throat cancers
Disease control OngoingSometimes, cancer patients receive an initial treatment, followed by additional treatment to lower the chance of cancer coming back. The standard or usual treatment for this type of disease is initially having radiation therapy at the same time as chemotherapy (with a drug called…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can ultrasound take the guesswork out of spinal anesthesia?
Knowledge-focused Recruiting nowNeuraxial ultrasonography has been shown a safe and effective technique to enhance the overall success rate of lumbar puncture and reduce the number of injection attempts. However, the current blind palpation landmark technique is known to be highly inaccurate and may increase th…
Sponsor: KK Women's and Children's Hospital • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New hope for kids with liver cancer: international trial tests smarter chemo combos
Disease control OngoingThis partially randomized phase II/III trial studies how well, in combination with surgery, cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or hepatocellular carcinoma. Drugs used in chemotherapy, such as cisplatin, doxorubic…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
A pinprick test may forecast severe pain after C-Section
Knowledge-focused OngoingApproximately 20% women who undergo cesarean delivery would suffer from severe post-operative pain, which may further increase their risks from developing postpartum depression. Predictive factors such as pre-operative pain, age and anxiety could significantly contribute to post-…
Sponsor: KK Women's and Children's Hospital • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New hope for kids with tough neuroblastoma: triple therapy trial launches
Disease control OngoingNeuroblastoma, the most common extra-cranial solid tumour in children, remains one of the major challenges in paediatric oncology. A promising way to further improve outcome in this disease appears to be the development of adjuvant therapeutic strategies. In this research the ant…
Phase 1 • Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could early ibrutinib stop CLL before it starts?
Disease control CompletedThe standard approach to managing chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) is to wait until you have symptoms before treatment is given. The goal of this clinical research study is to learn if providing earlier treatment for CLL or SLL with ibrutin…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 13:06 UTC
-
Could a Tumor's genes reveal who can skip chemo?
Knowledge-focused Recruiting nowNeoadjuvant therapy has been widely applied to locally advanced rectal cancer. However, about 50% of patients receiving this therapy do not respond well as evidenced by the fact that their T or N stages are not effectively decreased judged by postoperative pathological examinatio…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New drug cocktail targets breast cancer brain metastases
Disease control CompletedThis research study is studying a drug called atezolizumab as a possible treatment HER2-positive metastatic breast cancer (MBC) that has spread to the brain. The names of the study drugs involved in this study are: * Atezolizumab * Pertuzumab * Trastuzumab
Phase 2 • Sponsor: Nancy Lin, MD • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can removing liver tumors alongside the whipple procedure extend life in stage IV pancreatic cancer?
Disease control OngoingThe purpose of this study is to demonstrate the feasibility of an aggressive multimodal approach among patients with stage IV pancreatic cancer (PAC) with isolated, low-volume hepatic metastasis (LVHM). We will evaluate and describe the surgical and overall outcomes of an initial…
Sponsor: Duke University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Botox shots may save Babies' shoulders from lifelong deformity
Disease control Recruiting nowIn children population with obstetrical brachial plexus palsy (OBPP), shoulder musculoskeletal deformity is the main cause of morbidity, with a loss of range of shoulder motion, pain and a reduction in social participation. Some uncontrolled studies shows that early injections of…
Phase 3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Urine test may spot kidney danger early in septic shock
Diagnosis Recruiting nowSeptic shock is one of the leading causes of death in patients admitted to the intensive care unit (ICU). Acute kidney injury (AKI) occurs in almost 50% of septic patients and is associated with significant mortality. Progression to the last stage (KDIGO stage 3) of AKI is an imp…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Glow-in-the-Dark dye could help surgeons zap brain tumors
Diagnosis Recruiting nowThe phase I/II trial studies the side effects and best dose of panitumumab-IRDye800 in diagnosing participants with malignant glioma who undergo surgery. Panitumumab-IRDye800 can attach to tumor cells and make them more visible using a special camera during surgery, which may hel…
Phase 1/2 • Sponsor: Stanford University • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Head-to-Head drug battle for rare kidney cancer
Disease control OngoingThe goal of this clinical research study is to compare the safety and effectiveness of cabozantinib and sunitinib when given to patients with metastatic (has spread) variant histology renal cell carcinoma (vhRCC), a type of kidney cancer. This is an investigational study. Caboza…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for elderly leukemia patients: drug combo shows promise
Disease control CompletedThis study is being done to determine if treatment with azacitidine and venetoclax is effective treatment for elderly patients with acute myeloid leukemia (AML) who have not received previous treatment. Azacitidine and venetoclax will be given as induction treatment followed by v…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy shows promise in bladder cancer fight
Disease control OngoingThis is a randomized, open-label, multi-center, global, phase III study to determine the efficacy and safety of Durvalumab + BCG combination therapy in the treatment of patients with non-muscle-invasive bladder cancer
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug may delay return of ovarian cancer
Disease control OngoingTo evaluate the efficacy, safety and tolerability of maintenance therapy with BGB-290(Pamiparib) versus placebo in Chinese participants with recurrent ovarian cancer who achieved a complete response (CR) or partial response (PR) after platinum-based chemotherapy
Phase 3 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug cocktail aims to shrink Hard-to-Treat liver and bile duct tumors
Disease control OngoingThis research study is studying a combination of drugs as a possible treatment for Hepatocellular Carcinoma or Biliary Tract Cancer. The interventions involved in this study are: * Durvalumab * Tremelimumab * Radiation Therapy
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC